Global financial woes threaten new UK radiotherapy centers

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 17 No 11
Volume 17
Issue 11

One of Europe’s leading cancer centers is fighting to recover £7.5 million ($13 million) from a failed Icelandic bank. The money, much of which was generated from charity fundraising, was earmarked for two new radiation therapy centers.

One of Europe’s leading cancer centers is fighting to recover £7.5 million ($13 million) from a failed Icelandic bank. The money, much of which was generated from charity fundraising, was earmarked for two new radiation therapy centers.

Christie NHS Foundation Trust of Manchester, UK, deposited the money with Kaupthing Singer and Friedlander (KSF), a UK subsidiary of Icelandic bank Kaupthing, just a few months ago. However, following the collapse of KSF in early October and its subsequent nationalization, depositors such as the Christie found they were unable to access their money.

The government of Iceland has guaranteed that no domestic savers will lose out from the bank’s collapse. However, the many overseas businesses and charities who invested in KSF are currently unsure when or if they will see their savings again.

Despite this setback, a hospital trust spokesperson said that it would move forward with plans to build two radiotherapy centers in Oldham and Salford at a cost of £17 million ($30 million) each.

“This money is for some of our future developments, which means that none of our current patient services will be aff ected. But it is vital we get this money. Vital for patients, staff , and all our generous supporters,” wrote Caroline Shaw, chief executive of the Christie, on her official hospital blog. “All of you can rest assured that we are doing everything possible to make this happen.”

Just £1 million ($1.8 million) of the money deposited by the Christie in KSF came from public funds. The remaining £6.5 million ($11.2 million) was raised through fundraising.

The hospital trust has applied to the UK Financial Services Compensation Scheme for legal advice on how to retrieve its money.

Recent Videos
Yale’s COPPER Center aims to address disparities and out-of-pocket costs for patients, thereby improving the delivery of complex cancer treatment.
7 experts are featured in this series.
7 experts are featured in this series.
A study presented at ASTRO 2025 evaluated the feasibility of using a unified cancer database to consolidate information gathered across 14 institutions.
Non-Hodgkin lymphoma and other indolent forms of disease may require sequencing new treatments for years or decades, said Scott Huntington, MD, MPH, MSc.
Fixed-duration therapy may be more suitable for younger patients, while continuous therapy may benefit those who are older with more comorbidities.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to look forward to at the 2025 ESMO Annual Congress, from hot topics and emerging trends to travel recommendations.
Andrezj Jakubowiak, MD, PhD, prioritizes KRd-based regimens for the treatment of high-risk newly diagnosed disease in the post-transplant setting.
2 KOLs are featured in this series.
Related Content